The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Relay Therapeutics Inc (NASDAQ: RLAY) closed at $7.83 in the last session, up 4.54% from day before closing price of $7.49. In other words, the price has increased by $4.54 from its previous closing price. On the day, 1.31 million shares were traded. RLAY stock price reached its highest trading level at $7.92 during the session, while it also had its lowest trading level at $7.53.
Ratios:
We take a closer look at RLAY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 19.14 and its Current Ratio is at 19.14. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On April 17, 2025, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $4.
Jefferies Upgraded its Hold to Buy on September 10, 2024, whereas the target price for the stock was revised from $10.60 to $16.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 03 ’25 when Patel Sanjiv sold 62,073 shares for $7.00 per share. The transaction valued at 434,511 led to the insider holds 703,215 shares of the business.
Rahmer Peter sold 21,394 shares of RLAY for $160,455 on Oct 29 ’25. The insider now owns 337,469 shares after completing the transaction at $7.50 per share. On Oct 28 ’25, another insider, Rahmer Peter, who serves as the insider of the company, sold 19,135 shares for $7.29 each. As a result, the insider received 139,494 and left with 358,863 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 1357114240 and an Enterprise Value of 794012288. For the stock, the TTM Price-to-Sale (P/S) ratio is 162.33 while its Price-to-Book (P/B) ratio in mrq is 2.22. Its current Enterprise Value per Revenue stands at 95.034 whereas that against EBITDA is -2.477.
Stock Price History:
The Beta on a monthly basis for RLAY is 1.57, which has changed by 0.75 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, RLAY has reached a high of $8.36, while it has fallen to a 52-week low of $1.77. The 50-Day Moving Average of the stock is 20.09%, while the 200-Day Moving Average is calculated to be 89.13%.
Shares Statistics:
According to the various share statistics, RLAY traded on average about 1.96M shares per day over the past 3-months and 2006690 shares per day over the past 10 days. A total of 172.63M shares are outstanding, with a floating share count of 130.18M. Insiders hold about 24.89% of the company’s shares, while institutions hold 74.70% stake in the company. Shares short for RLAY as of 1763078400 were 21371170 with a Short Ratio of 10.93, compared to 1760486400 on 21928192. Therefore, it implies a Short% of Shares Outstanding of 21371170 and a Short% of Float of 14.940000000000001.
Earnings Estimates
. The current market rating for Relay Therapeutics Inc (RLAY) reflects the collective analysis of 8.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.38 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$1.5 and -$2.08 for the fiscal current year, implying an average EPS of -$1.73. EPS for the following year is -$1.58, with 7.0 analysts recommending between -$1.43 and -$1.78.
Revenue Estimates
A total of 10 analysts have provided revenue estimates for RLAY’s current fiscal year. The highest revenue estimate was $38.4M, while the lowest revenue estimate was $8.36M, resulting in an average revenue estimate of $12.91M. In the same quarter a year ago, actual revenue was $10.01M
